The cost-utility of rotavirus vaccination with Rotarix TM (RIX4414) in the Netherlands

Research output: Contribution to journal › Article › Academic › peer-review

70 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{5b25b04e239e452eb4c240d941de682d,

title = "The cost-utility of rotavirus vaccination with Rotarix TM (RIX4414) in the Netherlands",

author = "Lucas Goossens and B Standaert and Nico Hartwig and AM Hovels and Maiwenn Al",

year = "2008",

doi = "10.1016/j.vaccine.2007.11.070",

language = "Undefined/Unknown",

volume = "26",

pages = "1118--1127",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - The cost-utility of rotavirus vaccination with Rotarix TM (RIX4414) in the Netherlands

AU - Goossens, Lucas

AU - Standaert, B

AU - Hartwig, Nico

AU - Hovels, AM

AU - Al, Maiwenn

PY - 2008

Y1 - 2008

U2 - 10.1016/j.vaccine.2007.11.070

DO - 10.1016/j.vaccine.2007.11.070

M3 - Article

C2 - 18215445

SN - 0264-410X

VL - 26

SP - 1118

EP - 1127

JO - Vaccine

JF - Vaccine

ER -